PPG Labs LLC

PPG Labs LLC was paid $3.41M by Medicaid between Jul 2022 and May 2024, across 34 billing codes. Its largest line is U0003, Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r — 49% of everything it billed.

Compared with peers

Next to other Clinical Medical Laboratory providers in Illinois

Rank by total paid#47 of 235

Median peer was paid$123K

This provider vs. median28×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2022	69,505	$2.41M
2023	40,623	$995K
2024incomplete	811	$7K

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
U0003	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r	49%	29,590	9,918	$1.67M
87811	Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19)	21%	18,853	7,816	$721K
U0005	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2	14%	26,663	9,792	$482K
G2023	Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source	13%	27,241	9,039	$449K
84443	Thyroid stimulating hormone (TSH)	<1%	922	896	$14K
87635	Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe	<1%	211	87	$10K
80053	Comprehensive metabolic panel	<1%	912	879	$8K
87653		<1%	233	80	$7K
84439		<1%	725	709	$6K
86258		<1%	457	456	$6K
86364		<1%	463	462	$6K
85025	Blood count; complete (CBC), automated, and automated differential WBC count	<1%	970	940	$5K

22 more codes

84681		<1%	416	$5K
83036	Hemoglobin; glycosylated (A1C)	<1%	724	$4K
82784		<1%	474	$4K
82306	Vitamin D; 25 hydroxy, includes fraction(s), if performed	<1%	442	$4K
80061	Lipid panel	<1%	752	$4K
82607		<1%	135	$2K
87491	Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe	<1%	17	$596.68
87591	Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe	<1%	17	$596.68
84305		<1%	27	$401.42
82746		<1%	35	$351.82
82570		<1%	62	$236.34
82043		<1%	61	$196.86
81003		<1%	103	$188.51
82533		<1%	12	$156.56
87637	Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV	<1%	100	$139.78
81001		<1%	46	$118.29
83550		<1%	12	$102.03
82728		<1%	12	$84.11
87070		<1%	15	$77.23
83540		<1%	12	$76.05
87081		<1%	15	$72.17
36415	Collection of venous blood by venipuncture	<1%	210	$52.55

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialALTAWAFSHAH, KHALED (CEO/OWNER)